Dainippon Sumitomo To Get Hold Of US Cancer Drug Start-Up
Thu, 03/01/2012 - 06:33 | 
Dainippon Sumitomo Pharma Co. declared its plans to buy U.S. biotechnology business enterprise Boston Biomedical Inc. for $200 million, with milestone payments potentially bringing the transaction to around 2.63 billion dollars.
Sun Pharmaceutical Industries stated that it has bagged nod from the US health watchdog for its generic Zyprexa Zydis pills, utiized in handling psychological disorder, in the US market.
AstaraZeneca Pharma India stated that it is undertaking voluntary recall of sterile products fabricated at its Bangalore plant.
Hyderabad based pharmaceutical maker Cheminnova has inked a JV deal with Brisbane-based neutraceuticals company Rapid Nutrition Ltd.
Tags: IT Raids On Aurobindo Pharma; Sun Pharma To Announce Quarterly Results On Feb 13
Aurobindo Pharma Ltd’s scrip dropped 5.67% on the Bombay Stock Exchange (BSE) on February 10 following reports of IT raids and sudden annulment of board conference.
Cambridge based Ironwood Pharmaceuticals has declared that it is offering up 5.3 million Class A scrips to aid toughen its balance sheet.
The ex biz development director of Takeda Pharmaceuticals International made $63,000 in profits from insider trading.
Sun Pharmaceuticals, India’s biggest drug manufacturer by market cap, is ready to declare its outcomes for the three month period ended December FY12 on February 13.
